Austar Lifesciences Limited (HKG:6118)

Austar Lifesciences Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	415	292	800	1,035	7,730	3,122
Market Cap Growth	39.66%	-63.46%	-22.77%	-86.61%	147.62%	17.79%
Enterprise Value	626	630	1,072	1,131	7,454	3,044
Last Close Price	0.81	0.57	1.56	2.02	15.08	6.09
PE Ratio	10.76	17.08	-	10.47	22.71	79.41
Forward PE	-	4.80	4.80	4.80	4.80	4.80
PS Ratio	0.26	0.18	0.41	0.43	3.13	2.03
PB Ratio	0.47	0.35	0.94	1.04	7.99	5.01
P/TBV Ratio	0.49	0.37	0.99	1.09	8.23	5.32
P/FCF Ratio	4.12	3.51	-	-	-	102.34
P/OCF Ratio	3.20	2.78	-	-	-	50.33
PEG Ratio	-	0.21	0.21	0.21	0.21	0.21
EV/Sales Ratio	0.39	0.39	0.55	0.46	3.01	1.98
EV/EBITDA Ratio	6.74	9.10	-	7.30	46.49	64.36
EV/EBIT Ratio	15.17	17.02	-	8.15	51.92	97.17
EV/FCF Ratio	6.21	7.56	-	-	-	99.81
Debt / Equity Ratio	0.44	0.51	0.64	0.38	0.20	0.15
Debt / EBITDA Ratio	4.32	4.89	-	2.15	1.06	1.36
Debt / FCF Ratio	3.88	5.13	-	-	-	2.98
Asset Turnover	0.70	0.71	0.78	0.97	1.18	1.01
Inventory Turnover	4.86	4.98	4.52	4.11	4.86	5.22
Quick Ratio	1.05	1.00	1.01	0.86	0.81	0.87
Current Ratio	1.37	1.31	1.34	1.32	1.46	1.35
Return on Equity (ROE)	4.15%	1.73%	-4.19%	12.04%	41.53%	6.15%
Return on Assets (ROA)	1.07%	1.02%	-1.13%	3.46%	4.27%	1.29%
Return on Invested Capital (ROIC)	2.77%	2.10%	-3.80%	11.51%	17.42%	5.07%
Return on Capital Employed (ROCE)	3.80%	3.90%	-4.20%	11.90%	12.90%	4.60%
Earnings Yield	9.29%	5.86%	-15.63%	9.55%	4.40%	1.26%
FCF Yield	24.29%	28.52%	-18.17%	-16.93%	-3.24%	0.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.